What is the regulatory status of DSIP (Intranasal)?

DSIP (Intranasal) regulatory status: Unapproved in the United States; WADA status not on prohibited list; research level preclinical. Clinical access for off-label use is via compounded prescription where permissible. International regulatory status varies by jurisdiction. For male hormonal and performance use specifically, the regulatory profile shapes which monitoring and supervision approaches are required.

What is the mechanism of action of DSIP (Intranasal)?

Same DSIP molecule delivered intranasally. The olfactory and trigeminal nerve pathways allow direct CNS access, sidestepping the BBB and producing faster onset on sleep-relevant brain regions. For male hormonal and performance applications specifically, the relevant downstream consequence is the cascade from receptor engagement to systemic effect: Same DSIP molecule delivered intranasally. The male physiology interpretation focuses on the pathway-level detail rather than on any single high-level summary.

What is the evidence base for DSIP (Intranasal)?

DSIP (Intranasal)'s evidence base sits at preclinical. The references on this page summarise 1 primary publication supporting the principal mechanism and applications. Where Phase II or Phase III human data exists for related indications, it is cited; where evidence is preclinical or limited to small case series, that is noted. The male physiology interpretation respects the actual evidence tier rather than over-stating mechanistic plausibility.

How should DSIP (Intranasal) be stored and reconstituted?

Lyophilised DSIP (Intranasal) stores at −20°C for 18–24 months. After reconstitution with bacteriostatic water, the solution holds at 4°C for 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Travel with cold packs in insulated containers; avoid prolonged exposure above 25°C. The standard reconstitution concentration is 1–2 mg/mL depending on the vial size.

Is DSIP (Intranasal) safe during pregnancy or breastfeeding?

DSIP (Intranasal), like most non-approved peptide therapeutics, does not have safety data supporting use during pregnancy or lactation. The default position is contraindication during pregnancy, lactation, and active conception, with discontinuation at least 2–3 cycles before planned conception. Approved indications (where they exist) may have specific guidance — verify with the prescribing physician.

How long until I see results from DSIP (Intranasal)?

Acute effects from DSIP (Intranasal) appear within the first week for downstream physiological adaptation. male hormonal and performance endpoints accumulate across 4–8 weeks; the typical 8–12 week cycle is calibrated to allow the full response window. Single-week evaluations consistently underestimate the response trajectory.

Home/ Compounds/ DSIP (Intranasal)

DSIP (Intranasal)

Men's Health

Men's-health clinics treat DSIP (Intranasal) as one component in a layered hormonal optimisation framework. Intranasal DSIP for direct CNS delivery via the olfactory pathway — bypasses systemic circulation and acts on sleep architecture faster than subcutaneous. The relevant questions for male users are: does it interact with the HPG axis, is it compatible with current TRT or HCG protocols, and what are its effects on prostate, hematocrit, and cardiovascular indices over a Rapid CNS uptake via olfactory route-pharmacokinetics DSIP (Intranasal) cycle? The sections below address each.

Male Physiology Applications

Strength & PowerMuscle MassTestosterone OptimisationRecoveryBody Composition (Male)

Key Takeaways

Male-physiology lens: DSIP (Intranasal) is evaluated against HPG-axis interaction, TRT compatibility, and prostate / cardiovascular considerations.
Mechanism: Same DSIP molecule delivered intranasally.
Male monitoring: baseline testosterone (total/free), LH, FSH, estradiol, prolactin, SHBG; 6-8 week follow-up panel.
Male dose: 100-300 mcg 1 spray before sleep via intranasal; cycle 8-12 weeks.
Male-physiology stack partners: Kisspeptin, Gonadorelin (GnRH), PT-141.

Male Physiology Mechanism

Same DSIP molecule delivered intranasally. The olfactory and trigeminal nerve pathways allow direct CNS access, sidestepping the BBB and producing faster onset on sleep-relevant brain regions. For men, the downstream consequences of this mechanism are evaluated against four operational domains: HPG-axis interaction, recovery and body composition, sexual function and prostate, and integration with concurrent TRT or HCG protocols. DSIP (Intranasal)'s relationship to each is examined below.

Compatibility with TRT and post-cycle protocols

For men currently on TRT or planning a post-cycle restart, DSIP (Intranasal) is typically compatible because it does not directly engage the HPG axis. The dominant interaction to watch for is on the metabolic and recovery layers rather than the hormonal layer. Where the molecule's pharmacology overlaps with HCG, gonadorelin, or kisspeptin, dose layering is the standard approach.

Sexual function and prostate considerations

Where DSIP (Intranasal) alters circulating LH, testosterone, or local androgen signalling, prostate considerations become relevant for men over 40. Baseline PSA, periodic re-check, and avoidance of stacking that compounds androgenic load are all reasonable precautions. For molecules whose effects are predominantly outside the HPG axis, the prostate consideration is largely background.

Male body composition and performance response

Male users typically respond to DSIP (Intranasal) on the recovery, lean-mass, or visceral-fat dimension depending on the compound's primary pharmacology. Same DSIP molecule delivered intranasally. The olfactory and trigeminal nerve pathways allow direct CNS access, sidestepping the BBB and producing faster onset on sleep-relevant brain regions. For men whose body composition goals are driven by training, the dose-timing relative to workouts and sleep is often the critical lever rather than the absolute dose itself.

Male Physiology Applications

HPG Axis Support

Where male users target hpg axis support, DSIP (Intranasal) is typically integrated with the broader hormonal protocol — TRT, kisspeptin, gonadorelin, or HCG — rather than used in isolation. The integration approach varies by clinic.

Hair Loss

Hair Loss in men responds to DSIP (Intranasal) with effect sizes that vary substantially by baseline status — men with documented suboptimal status respond more strongly than those at the upper end of normal. The protocol pattern in clinical use reflects this.

Erectile Function

For erectile function in male users, DSIP (Intranasal) is most-effective when paired with comprehensive labs (testosterone total/free, LH, FSH, estradiol sensitive, prolactin, SHBG) at baseline and follow-up. Cycle length 8–12 weeks with re-evaluation.

Body Composition (Male)

Where male users target body composition (male), DSIP (Intranasal) is typically integrated with the broader hormonal protocol — TRT, kisspeptin, gonadorelin, or HCG — rather than used in isolation. The integration approach varies by clinic.

Dosing Protocol

Goal	Route	Dose	Cycle
Standard protocol	Intranasal	100-300 mcg	8–12 weeks on / 4 weeks off
Conservative starter	Intranasal	60-300 mcg	4–6 weeks initial cycle
Men's Health focus	Intranasal	100-300 mcg	1 spray before sleep
Maintenance phase	Intranasal	70-300 mcg	Ongoing with periodic pauses

Dose timing for DSIP (Intranasal) is less time-sensitive given the longer half-life. Consistency through the cycle is more important than the precise clock time of individual doses.

Stacking

DSIP (Intranasal) stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from men's-health clinicians.

DSIP (Intranasal) + Kisspeptin: Activates the KISS1R (GPR54) on GnRH neurons in the hypothalamus, triggering GnRH release. Pairs naturally with DSIP (Intranasal)'s mechanism in male physiology protocols.
DSIP (Intranasal) + Gonadorelin (GnRH): Binds the GnRH receptor on anterior pituitary gonadotrophs in a pulsatile fashion to stimulate LH (and to a lesser extent FSH) release. Pairs naturally with DSIP (Intranasal)'s mechanism in male physiology protocols.
DSIP (Intranasal) + PT-141: Activates MC4R in the hypothalamus and other CNS regions involved in sexual response. Pairs naturally with DSIP (Intranasal)'s mechanism in male physiology protocols.
DSIP (Intranasal) + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with DSIP (Intranasal)'s mechanism in male physiology protocols.

Safety & Regulatory Status

WADA: Not on prohibited list FDA: Unapproved Research: Preclinical

Excellent tolerability. Mild nasal irritation possible.

Lens-specific safety considerations for male physiology use of DSIP (Intranasal): Excellent tolerability. Mild nasal irritation possible. Additional male physiology monitoring at baseline and 6–8 week follow-up is appropriate.

Clinical Evidence

Primary

DSIP — characterisation and effects on sleep

PMID 6324019

DSIP (Intranasal) vs Related Peptides

Compound	Profile	Onset	Best For
DSIP (Intranasal)	Neuropeptide (sleep, intranasal)	Rapid CNS uptake via olfactory route	Men's Health
Kisspeptin	Hypothalamic upstream regulator of GnRH	~28 min IV	The upstream master regulator of GnRH neurons — driving the entire HPG axis from above
Gonadorelin (GnRH)	Hypothalamic decapeptide	~2-4 min	The natural decapeptide that drives pituitary release of LH and FSH — used clinically and increasingly as an HCG alternative during testosterone therapy
PT-141	Melanocortin receptor agonist	~2-3 hr	An MC3R/MC4R agonist derived from Melanotan II — FDA-approved as bremelanotide for HSDD in premenopausal women

Frequently Asked Questions

Best time of day to dose for male users?

The pragmatic schedule is morning fasted for compounds engaging the GH axis (preserving the natural overnight pulse), evening for compounds supporting sleep, and PRN for compounds with acute effects (PT-141, etc.). The schedule should fit the user's daily reality more than the textbook ideal.

What blood work should I run on this protocol?

Standard male protocol baseline: total and free testosterone, LH, FSH, estradiol (sensitive), prolactin, SHBG, fasting glucose, HbA1c, hsCRP, lipid panel, CBC, CMP. Follow-up at week 6–8 with the same panel. Add IGF-1 for any GH-axis compound. Add PSA for men over 40.

Will DSIP (Intranasal) affect fertility or sperm quality?

Sperm parameters reflect a 70–90 day spermatogenic cycle, so any meaningful effect on sperm count and motility requires at least one full cycle to manifest. DSIP (Intranasal)'s direct effect on spermatogenesis varies by mechanism. Men actively pursuing fertility should baseline semen analysis before and after cycles to track.

Can I use DSIP (Intranasal) during a cut?

Yes, and several compounds in this class are specifically protective of lean mass in caloric deficit. The dose-timing relative to training and the protein intake matter more than the absolute dose. Cardiovascular and metabolic monitoring continues to apply.

What is the standard dosing protocol for DSIP (Intranasal)?

Conventional DSIP (Intranasal) dosing is 100-300 mcg 1 spray before sleep via intranasal. For male hormonal and performance use specifically, the cycle pattern is typically 8–12 weeks on followed by a 4 week off-period. Higher doses are studied in advanced protocols but produce diminishing dose-response in the published literature.

How does DSIP (Intranasal)'s half-life affect dosing?

DSIP (Intranasal) has a plasma half-life of Rapid CNS uptake via olfactory route, which is moderate, supporting once-daily dosing in most protocols. The receptor occupancy curve under 1 spray before sleep dosing at 100-300 mcg per dose explains the typical onset timeline for male hormonal and performance endpoints.

Clinical Protocol

Start a DSIP (Intranasal) Protocol

Alukard provides physician-supervised men's health protocols with GMP-certified DSIP (Intranasal) and GMP-certified compounds with comprehensive hormone panels.

Get Protocol

Quick Facts

Molecular weight: 848 Da
Sequence length: 9 aa
Half-life: Rapid CNS uptake via olfactory route
WADA: Not on prohibited list
FDA: Unapproved
Research: Preclinical

Stack Partners

Kisspeptin

Gonadorelin (GnRH)

PT-141

Ipamorelin

CJC-1295 without DAC (Mod GRF 1-29)

Research Note

All male physiology applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for DSIP (Intranasal) unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.

Physician-supervised men's health protocols

Start Your Male Physiology Protocol for DSIP (Intranasal)

Alukard provides physician-supervised men's health protocols with GMP-certified compounds with comprehensive hormone panels.

Get a Physician Consultation View All Compounds

HIPAA Compliant · GMP Certified · Physician Supervised